Ranking Member Raskin's Statement on Fifth Circuit Court Decision on Abortion Access

Press Release

"Today's panel decision in the Fifth Circuit Court of Appeals upholding restrictions on mifepristone, a key drug used in medication abortion, deepens our national crisis with right-wing judicial activism. Following a runaway anti-choice district judge, the Fifth Circuit has substituted its own judgment for the regulatory expertise of the FDA, defying decades of clear scientific evidence and expert medical opinion. This decision limits the use of mifepristone to the initial seven weeks of pregnancy--before many women even know they're pregnant--and undercuts the right of millions of American women to choose their own medical care. If allowed to take effect after appeal, this decision will restrict safe abortion access for all women, and in particular those who already face health inequities such as people of color and people with less income and wealth."

Source